Suppr
超能文献

PD-1 inhibitors effective in hodgkin lymphoma.

出版信息

Cancer Discov. 2015 Feb;5(2):102-3. doi: 10.1158/2159-8290.CD-NB2015-002. Epub 2015 Jan 9.

DOI:10.1158/2159-8290.CD-NB2015-002

PMID:25656882

Abstract

摘要

相似文献

PD-1 inhibitors effective in hodgkin lymphoma.

Cancer Discov. 2015 Feb;5(2):102-3. doi: 10.1158/2159-8290.CD-NB2015-002. Epub 2015 Jan 9.

[Not Available].

Bull Cancer. 2016 Nov;103 Suppl 1:S160-S163. doi: 10.1016/S0007-4551(16)30374-5.

Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin Lymphoma.

Cancer J. 2016 Jan-Feb;22(1):17-22. doi: 10.1097/PPO.0000000000000164.

Checkpoint Inhibition in Hodgkin Lymphoma - a Review.

Oncol Res Treat. 2017;40(11):654-660. doi: 10.1159/000481800. Epub 2017 Oct 20.

Checkpoint inhibitors in Hodgkin's lymphoma.

Eur J Haematol. 2016 Apr;96(4):335-43. doi: 10.1111/ejh.12697. Epub 2015 Dec 11.

PD-1 Blockers.

Cell. 2015 Aug 27;162(5):937. doi: 10.1016/j.cell.2015.07.045.

Clinical Trials of PD-1 and PD-L1 inhibitors in NSCLC.

Clin Adv Hematol Oncol. 2014 Jan;12(1 Suppl 1):14-6.

Programmed death protein 1 inhibitors making inroads in multiple cancers.

J Natl Cancer Inst. 2015 May 9;107(5). doi: 10.1093/jnci/djv141. Print 2015 May.

Targeting Immune System Alterations in Hodgkin Lymphoma.

Curr Hematol Malig Rep. 2017 Aug;12(4):358-369. doi: 10.1007/s11899-017-0398-6.

Pembrolizumab for classical Hodgkin's lymphoma.

Lancet Oncol. 2016 Aug;17(8):e324. doi: 10.1016/S1470-2045(16)30301-1. Epub 2016 Jul 7.

引用本文的文献

Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.

Cancer Immunol Immunother. 2022 Jul;71(7):1597-1609. doi: 10.1007/s00262-021-03095-z. Epub 2021 Nov 3.

Assessment of tumor mutation burden calculation from gene panel sequencing data.

Onco Targets Ther. 2019 May 6;12:3401-3409. doi: 10.2147/OTT.S196638. eCollection 2019.

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.

J Cancer. 2018 Jun 6;9(13):2302-2307. doi: 10.7150/jca.24932. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

PD-1 inhibitors effective in hodgkin lymphoma.

Cancer Discov. 2015 Feb;5(2):102-3. doi: 10.1158/2159-8290.CD-NB2015-002. Epub 2015 Jan 9.

[Not Available].

Bull Cancer. 2016 Nov;103 Suppl 1:S160-S163. doi: 10.1016/S0007-4551(16)30374-5.

Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin Lymphoma.

Cancer J. 2016 Jan-Feb;22(1):17-22. doi: 10.1097/PPO.0000000000000164.

Checkpoint Inhibition in Hodgkin Lymphoma - a Review.

Oncol Res Treat. 2017;40(11):654-660. doi: 10.1159/000481800. Epub 2017 Oct 20.

Checkpoint inhibitors in Hodgkin's lymphoma.

Eur J Haematol. 2016 Apr;96(4):335-43. doi: 10.1111/ejh.12697. Epub 2015 Dec 11.

PD-1 Blockers.

Cell. 2015 Aug 27;162(5):937. doi: 10.1016/j.cell.2015.07.045.

Clinical Trials of PD-1 and PD-L1 inhibitors in NSCLC.

Clin Adv Hematol Oncol. 2014 Jan;12(1 Suppl 1):14-6.

Programmed death protein 1 inhibitors making inroads in multiple cancers.

J Natl Cancer Inst. 2015 May 9;107(5). doi: 10.1093/jnci/djv141. Print 2015 May.

Targeting Immune System Alterations in Hodgkin Lymphoma.

Curr Hematol Malig Rep. 2017 Aug;12(4):358-369. doi: 10.1007/s11899-017-0398-6.

Pembrolizumab for classical Hodgkin's lymphoma.

Lancet Oncol. 2016 Aug;17(8):e324. doi: 10.1016/S1470-2045(16)30301-1. Epub 2016 Jul 7.

引用本文的文献

Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.

Cancer Immunol Immunother. 2022 Jul;71(7):1597-1609. doi: 10.1007/s00262-021-03095-z. Epub 2021 Nov 3.

Assessment of tumor mutation burden calculation from gene panel sequencing data.

Onco Targets Ther. 2019 May 6;12:3401-3409. doi: 10.2147/OTT.S196638. eCollection 2019.

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.

J Cancer. 2018 Jun 6;9(13):2302-2307. doi: 10.7150/jca.24932. eCollection 2018.

Suppr超能文献

PD-1 inhibitors effective in hodgkin lymphoma.

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译